| http://www.w3.org/ns/prov#value | - The third that will sell vaccines, cancer treatments, and consumer products.The company said overall revenue fell 7 percent to $12.97 billion, which is just short of the $13.21 billion analysts polled by FactSet had predicted.Revenue from Prevnar 13, a vaccine for ear infections, meningitis and other pneumococcal infections
|
